Evaluation of the Effectiveness of a Mobile Application Developed for Hemodialysis Patients.
Not yet recruitingNot applicableNCT07211100
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This study aims to evaluate the effectiveness of a mobile health application developed for adult patients undergoing hemodialysis treatment. The mobile application includes modules on adherence to medication, diet, and fluid restrictions, symptom management (fatigue, pain, itching), nutrition guidance, exercise recommendations, and motivational content. It also features reminder notifications, an "Ask the Expert" module, and personal symptom tracking. The research will be conducted as a single-center, single-blind, randomized controlled experimental study. Participants will be assigned to intervention and control groups using block randomization. The intervention group will receive the mobile application, while the control group will receive standard care. Assessments will be carried out at baseline (T0), 1st month (T1), and 2nd month (T2). The measurement tools to be used include the End-Stage Renal Disease Adherence Questionnaire (ESRD-AQ), Post-Dialysis Fatigue Scale, 5-D Itch Scale, Visual Analog Scale (VAS) for pain, and the Mobile Application Usability Scale. In addition, clinical parameters such as serum potassium, phosphorus, and albumin will be evaluated. A total of 72 patients (36 intervention, 36 control) will be included in the study. This study aims to assess the impact of a mobile health application on treatment adherence, symptom management, and clinical parameters among hemodialysis patients, and to develop a digital health model that can be integrated into nursing care.
Study details
- Official title
- Evaluation of the Impact of a Mobile Application Developed for Hemodialysis Patients on Treatment Adherence, Symptom Management and Clinical Parameters.
- Conditions
- End-Stage Renal Disease Requiring Haemodialysis
- Mobile Application
- Interventions
- Behavioral: Mobile Health Application
- Sponsor
- Saglik Bilimleri Universitesi
- Collaborators
- Gümüşhane Universıty
- Start date
- 2025-11
- Primary completion
- 2025-12
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- Turkey (Türkiye)
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Age ≥ 18 years. * Diagnosed with end-stage renal disease (ESRD). * Receiving maintenance hemodialysis treatment for at least 3 months. * Able to use a smartphone and willing to install the mobile health application. * Voluntarily agreeing to participate in the study and providing written informed consent. Exclusion Criteria: * Patients with cognitive impairment, severe psychiatric disorders, or communication barriers that may interfere with participation. * Patients with visual or hearing impairments that prevent the use of the mobile application. * Patients who have undergone kidney transplantation or are scheduled for transplantation within the study period. * Patients with serious comorbid conditions requiring hospitalization (e.g., advanced cancer, severe heart failure). * Participation in another interventional clinical trial within the past 3 months.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT07211100